Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma: Phase III Study.
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Interferon alpha-2b (Primary) ; Dacarbazine; Fotemustine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 May 2011 Additional lead trial centres and investigators identified as reported by ClinicalTrials.gov.
- 24 May 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 01 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.